interaction
Showing 1 - 25 of >10,000
Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)
Recruiting
- Drug Drug Interaction
- Digoxin
- +4 more
-
Guangzhou, ChinaThe First Affiliated Hospital of Guangzhou University of Chinese
Jul 13, 2023
Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole
Completed
- Drug-drug Interaction Study
- SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Nov 20, 2023
Healthy Volunteers Trial in Jinan (Cohort 1: SIM0417/ritonavir and itraconazole, Cohort 2: SIM0417/ritonavir and rifampicin,
Active, not recruiting
- Healthy Volunteers
- Cohort 1: SIM0417/ritonavir and itraconazole
- +2 more
-
Jinan, Shandong, ChinaShandong First Medical University
Jan 13, 2023
Herbal Interaction Trial in Spokane (Kratom, Oxycodone)
Not yet recruiting
- Herbal Interaction
- Kratom
- Oxycodone
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Apr 26, 2023
Hypertension, Periodontitis Trial (Scaling and root planing)
Completed
- Hypertension
- Periodontitis
- Scaling and root planing
- (no location specified)
Feb 14, 2023
Healthy Volunteer Study Trial in Québec (Cohort 1 BEM + Ruzasvir, Cohort 2 Ruzasvir + BEM)
Recruiting
- Healthy Volunteer Study
- Cohort 1 BEM + Ruzasvir
- Cohort 2 Ruzasvir + BEM
-
Québec, Montreal, Quebec, CanadaAtea Study Site
Feb 9, 2023
Diabetes in Adults Trial in Shanghai (Hydrochlorothiazide?Henagliflozin Proline)
Completed
- Diabetes in Adults
- Hydrochlorothiazide、Henagliflozin Proline
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 12, 2023
Drug Drug Interaction, Warfarin, Midazolam Trial in Guangzhou (ZSP1273)
Active, not recruiting
- Drug Drug Interaction
- +2 more
-
Guangzhou, Chinathe Second Affiliated Hospital of Guangzhou Medical University
Jul 4, 2023
Healthy Trial (Siemens Quadra PET/CT and [18F]FDG, Apple i-Watch)
Not yet recruiting
- Healthy
- Siemens Quadra PET/CT and [18F]FDG
- Apple i-Watch
- (no location specified)
Jun 30, 2023
Grandparents, Growth Disorders, Development, Child Trial in Istanbul (Interaction-Based Early Education Program)
Not yet recruiting
- Grandparents
- +4 more
- Interaction-Based Early Education Program
-
Istanbul, TurkeyMarmara University
Jun 22, 2023
Healthy, Drug-Drug Interaction Trial in Shanghai (JMKX000623, Metformin)
Active, not recruiting
- Healthy
- Drug-Drug Interaction
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Sep 30, 2023
Virtual Reality, Social Interaction, Attention-deficit/Hyperactivity Disorder Trial in Hong Kong (Virtual reality, Traditional
Recruiting
- Virtual Reality
- +2 more
- Virtual reality
- Traditional social skills training
-
Hong Kong, Hong KongKa Po WONG
Mar 9, 2023
Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)
Not yet recruiting
- Myelofibrosis
- TQ05105 tablets
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Aug 30, 2023
Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)
Active, not recruiting
- Drug Interaction
- Nitazoxanide
- "Nitazoxanide" and "atazanavir/ritonavir" separately
-
Ile-Ife, Osun, NigeriaObafemi Awolowo University
Jan 8, 2023
Genetic Determinants of Clindamycin/Rifampin Interaction
Completed
- VA Drug Interaction
-
Paris, FranceGroupe Hospitalier Diaconesses Croix Saint Simon
Oct 24, 2022
Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)
Recruiting
- Drug Interaction
- ZX-7101A
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 21, 2023
Interaction Between Hepatitis C Virus Infection and Pregnancy
Enrolling by invitation
- Hepacivirus
- Pregnancy
- HCV infection status
-
Beijing, ChinaBeijing Ditan Hospital
Jun 24, 2023
Erectile Dysfunction Trial in Peking (Tunodafil Hydrochloride Tablets, Placebo, Alcohol)
Completed
- Erectile Dysfunction
- Tunodafil Hydrochloride Tablets
- +2 more
-
Peking, ChinaPeking University People's Hospital
Jul 28, 2023
Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)
Completed
- Healthy Participant
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 11, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- +4 more
-
Tempe, ArizonaCelerion
Aug 15, 2023